-
Something wrong with this record ?
Anti-inflammatory and antioxidant properties of chemical constituents of Broussonetia papyrifera
M. Malaník, J. Treml, V. Leláková, D. Nykodýmová, M. Oravec, J. Marek, K. Šmejkal
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Anti-Inflammatory Agents chemistry isolation & purification pharmacology MeSH
- Antioxidants chemistry isolation & purification pharmacology MeSH
- Broussonetia chemistry MeSH
- Interleukin-1beta antagonists & inhibitors biosynthesis MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Lipopolysaccharides antagonists & inhibitors pharmacology MeSH
- Molecular Structure MeSH
- NF-kappa B analysis antagonists & inhibitors biosynthesis MeSH
- Oxidative Stress drug effects MeSH
- THP-1 Cells MeSH
- Tumor Necrosis Factor-alpha antagonists & inhibitors biosynthesis MeSH
- Transcription Factor AP-1 analysis antagonists & inhibitors biosynthesis MeSH
- Cell Survival drug effects MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Extensive phytochemical analysis of the CHCl3-soluble part of an ethanolic extract of branches and twigs of Broussonetia papyrifera led to the isolation of fourteen compounds, including a novel 5,11-dioxabenzo[b]fluoren-10-one derivative named broussofluorenone C (12). The isolated compounds 1-14 were characterized based on their NMR and HRMS data, and examined for their anti-inflammatory activities in LPS-stimulated THP-1 cells as well as for their cellular antioxidant effects. Compounds 7-10 and 12 showed inhibitory effects on NF-κB/AP-1 activation and compounds 7-9 were subsequently confirmed to suppress the secretion of both IL-1β and TNF-α in LPS-stimulated THP-1 cells more significantly than the prednisone used as a positive control. In the CAA assay, compound 10 exhibited the greatest antioxidant effect, greater than that of the quercetin used as a positive control. The results show possible beneficial effects and utilization of B. papyrifera wood in the treatment of inflammatory diseases as well as oxidative stress.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011912
- 003
- CZ-PrNML
- 005
- 20210507101717.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2020.104298 $2 doi
- 035 __
- $a (PubMed)33011537
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Malaník, Milan $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1, 61200 Brno, Czech Republic. Electronic address: milan.malanik@seznam.cz
- 245 10
- $a Anti-inflammatory and antioxidant properties of chemical constituents of Broussonetia papyrifera / $c M. Malaník, J. Treml, V. Leláková, D. Nykodýmová, M. Oravec, J. Marek, K. Šmejkal
- 520 9_
- $a Extensive phytochemical analysis of the CHCl3-soluble part of an ethanolic extract of branches and twigs of Broussonetia papyrifera led to the isolation of fourteen compounds, including a novel 5,11-dioxabenzo[b]fluoren-10-one derivative named broussofluorenone C (12). The isolated compounds 1-14 were characterized based on their NMR and HRMS data, and examined for their anti-inflammatory activities in LPS-stimulated THP-1 cells as well as for their cellular antioxidant effects. Compounds 7-10 and 12 showed inhibitory effects on NF-κB/AP-1 activation and compounds 7-9 were subsequently confirmed to suppress the secretion of both IL-1β and TNF-α in LPS-stimulated THP-1 cells more significantly than the prednisone used as a positive control. In the CAA assay, compound 10 exhibited the greatest antioxidant effect, greater than that of the quercetin used as a positive control. The results show possible beneficial effects and utilization of B. papyrifera wood in the treatment of inflammatory diseases as well as oxidative stress.
- 650 _2
- $a antiflogistika $x chemie $x izolace a purifikace $x farmakologie $7 D000893
- 650 _2
- $a antioxidancia $x chemie $x izolace a purifikace $x farmakologie $7 D000975
- 650 _2
- $a Broussonetia $x chemie $7 D031623
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-1beta $x antagonisté a inhibitory $x biosyntéza $7 D053583
- 650 _2
- $a lipopolysacharidy $x antagonisté a inhibitory $x farmakologie $7 D008070
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a NF-kappa B $x analýza $x antagonisté a inhibitory $x biosyntéza $7 D016328
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a THP-1 buňky $7 D000074084
- 650 _2
- $a transkripční faktor AP-1 $x analýza $x antagonisté a inhibitory $x biosyntéza $7 D018808
- 650 _2
- $a TNF-alfa $x antagonisté a inhibitory $x biosyntéza $7 D014409
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Treml, Jakub $u Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1, 61200 Brno, Czech Republic
- 700 1_
- $a Leláková, Veronika $u Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1, 61200 Brno, Czech Republic
- 700 1_
- $a Nykodýmová, Daniela $u Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1, 61200 Brno, Czech Republic
- 700 1_
- $a Oravec, Michal $u Global Change Research Institute of the Czech Academy of Sciences, Bělidla 986/4a, 60300 Brno, Czech Republic
- 700 1_
- $a Marek, Jaromír $u X-ray Diffraction and Bio-SAXS Core Facility, Central European Institute of Technology, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic
- 700 1_
- $a Šmejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1, 61200 Brno, Czech Republic. Electronic address: karel.mejkal@post.cz
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 104, č. - (2020), s. 104298
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33011537 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101717 $b ABA008
- 999 __
- $a ok $b bmc $g 1650315 $s 1132291
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 104 $c - $d 104298 $e 20200919 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20210420